BIIB

Biogen Inc (NASDAQ: BIIB) Sec Form 10K

Biogen Inc (NASDAQ: BIIB) Sec Form 8K

Shares of Biogen Inc (BIIB) rose 8.53% to $201.18 at close on Friday following the release of fourth-quarter and full-year…

Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower revenues and adjusted earnings for the fourth quarter of fiscal 2025. The…

Biogen Inc (NASDAQ: BIIB) Q4 2025 Earnings Conference

Biogen Inc (NASDAQ: BIIB) Q4 2025 Earnings Call dated Feb. 12, 2025 Corporate Participants: Tim Power — Head of Investor…

Biogen Inc (NASDAQ: BIIB) Q2 2025 Earnings Call dated Jul. 31, 2025 Corporate Participants: Tim Power — Head of Investor…

Biogen Inc (NASDAQ: BIIB) Q3 2025 Earnings Call dated Oct. 30, 2025 Corporate Participants: Tim Power — Head of Investor…

Biogen Inc. (NASDAQ: BIIB) reported its fourth quarter 2024 earnings results today. Total revenue increased 3% year-over-year to $2.5 billion.…

Biogen Inc. (NASDAQ: BIIB) reported its third quarter 2024 earnings results today. Total revenue decreased 3% year-over-year to $2.46 billion.…